AstraZeneca
AstraZeneca warns of shifting UK vaccine production to US
Deadlock with the new Labour government over plans to cut state aid, the Financial Times reported on Thursday
Ryanair dominates Irish market with share buyback announcement
European stocks were flat after latest US jobless claims data helped ease concerns of slowdown
Markets hit a wall amid fears of US economic slowdown
Financials and tech stocks worst hit as indices show a sea of red
AstraZeneca targets $80bn revenue by 2030
Anglo-Swedish drugmaker to launch 20 new medicines by end of decade
Big pay rise for Smith & Nephew chief shows US-style packages have arrived in Europe
Company says corporate talent is increasingly mobile in a globalised world and investors must pay up if they want to retain top executives
Europe falling behind US and China in pharma innovation, warns AstraZeneca chief
Continent’s drugmakers need to pay up to attract and retain talent, says Pascal Soriot
Europe’s magnificent 11 stocks – the Granolas
Continent’s top firms drove most of European equity gains last year
Ireland is one of slowest countries in Europe for medical reimbursment, it’s ‘a bit of a travesty for patients’
AstraZeneca’s Alex Wilkes warns Ireland needs to speed up access to medicines and expand the breadth of its pharma sector
Global stocks flat as investors await earnings from heavyweights
Holiday for US markets make for thin trading
European shares edge lower despite strong earnings from Unilever and Kering
Smurfit Kappa advances in Dublin, while Disney gains on Wall Street
AstraZeneca suffers low profit, driving down shares
Company entered obesity drug race last year but its experimental pill remains in early-stage tests
‘I work in a frustration factory’: how to make workplaces run better
Stanford professors Huggy Rao and Bob Sutton share tips to remove bad ‘friction’ in companies
AstraZeneca to buy cancer drug developer in China for up to $1.2bn
Astra will acquire Shanghai-based Gracell for $2 a share
‘An offhand comment’: Louise Richardson on the President’s broadside in the neutrality debate
The Waterford-born academic and foreign policy expert was a low-profile figure until she became the focus of sharp criticism for chairing the Government’s forum on security
Global markets subdued as investors await interest rate announcements
In Dublin, shares were down on the day, in line with European peers.
European shares cap strong weak with Friday rebound
Iseq index finished the session up 1%, driven by growing optimism about the path for interest rates
European markets edge lower after batch of downbeat company earnings
Investors keep eye on geopolitical tensions ahead of trip by US president Joe Biden to Israel
AstraZeneca to pay €375m to settle Nexium, Prilosec litigation in US
Claims were filed against the company for failing to warn patients about the risk of chronic kidney disease
US targets 10 drugs for pricing negotiations in crackdown on costs
Expensive medicines made by Pfizer, J&J and Merck selected for talks in biggest pharma shake-up in decades
European stock markets edge lower after mixed bag of company earnings
Aer Lingus owner IAG was the biggest gainer on the FTSE 100 index
Healthcare gloom wins out over bullish miners to start off second half of the year
Irish banks made ground while US indices were also ahead in truncated session ahead of indpendence day holiday
Underlying revenues at PM Group up 14% amid expansion
Project delivery specialist reported operating profits of €44m for 2022
European shares slide, Germany’s Dax retreats from record high
Trading thin on Monday with US markets shut for a public holiday
AstraZeneca drafts plan to spin off China business amid tensions
Anglo-Swedish drugmaker views listing a separate unit in Hong Kong as potential shelter from global strife
European shares put in best day in two months as techs shine
Main benchmark logs steep weekly decline on growing concerns over slowing global economy and uncertainty around US debt ceiling talks
Markets little changed as US inflation data holds few surprises
US consumer price index comes in marginally below expectations, with core prices as expected
GSK sales fall after demand for Covid treatment plummets
Drugmaker’s Xevudy fails to tackle most prevalent variants of coronavirus, say US regulators
Unused Covid-19 vaccines worth €95m discarded by HSE last year
More than 850,000 doses of past-expiry date Covid-19 vaccines thrown out
China says it is open for business again as western CEOs descend on Beijing
Multinational chief executives stress the importance of creating a more level playing field if China wants to attract more foreign investment
Pfizer’s RSV vaccine wins US panel’s backing for safety in older people
Questions remain about hospitalisation and side effects but drugmaker stays step ahead of British group GSK which faces similar panel
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices